Rules-Based Medicine Acquires Intellectual Property Assets of Satoris, Inc.

Rules-Based Medicine (RBM) has expanded its biomarker discovery portfolio with the acquisition of technology from Satoris, Inc. RBM, recently acquired by Myriad Genetics, expects this acquisition to advance their ongoing diagnostics R&D for neurodegenerative illnesses with the belief that early detection will be critical for advancing the discovery of treatments.

Click here to read more.

Share this: